Phase I Study of Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2017
At a glance
- Drugs Perifosine (Primary) ; Temsirolimus
- Indications Medulloblastoma; Neuroblastoma; Solid tumours
- Focus Adverse reactions
- 09 Mar 2017 Status changed from active, no longer recruiting to completed.
- 08 Dec 2016 Planned End Date changed from 1 Jan 2017 to 1 Jan 2018.
- 08 Dec 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2018.